|
Gemcitabine-paclitaxel approved as first-line metastatic breast cancer therapy USA Publish Date : 6/10/2004 5:45:00 PM Source : Skincareindia.com Team
In the pivotal clinical trial, median survival for 267 patients receiving combination therapy was 18.5 months, compared with 15.8 months for the 262 patients receiving paclitaxel alone. Also, average time to disease progression increased for patients on the gemcitabine–paclitaxel regimen (5.2 months versus 2.9 months), and response rates—defined as decreased pain, decreased analgesic use, and improved quality of life—were higher for patients on combination therapy. Gemcitabine alone is also indicated for treatment of locally advanced or metastatic pancreatic cancer and, in combination with cisplatin, for treatment of locally advanced or metastatic non–small-cell lung cancer. Paclitaxel has previously approved indications, either alone or in combination with other chemotherapy agents, for treatment of ovarian, node-positive and metastatic breast, and non–small-cell lung cancer, as well as AIDS-related Kaposi’s sarcoma. |
|
Microsoft Says It Wooed SAP, and Oracle Trial Takes Note
Publish Date : 6/10/2004 7:52:00 PM In a trial that promises to shed light on the private dealings of the computer software industry, the first bombshell dropped yesterday even before the courtroom doors opened in San Francisco. Game Maker Misses Earnings Target and Cuts 2004 Forecast Publish Date : 6/10/2004 7:50:00 PM Financial disappointments continue to take a toll on Take-Two Interactive Software, the maker of the hit video game... Gemcitabine-paclitaxel approved as first-line metastatic breast cancer therapy USA Publish Date : 6/10/2004 5:45:00 PM The FDA has approved the combination of gemcitabine hydrochloride (Gemzar—Lilly) and paclitaxel (Taxol—Bristol-Myers Squibb and generics) as first-line treatment of women with metastatic... Gemcitabine-paclitaxel approved as first-line metastatic breast cancer therapy USA Publish Date : 6/10/2004 5:31:00 PM The FDA has approved the combination of gemcitabine hydrochloride (Gemzar—Lilly) and paclitaxel (Taxol—Bristol-Myers Squibb and generics) as first-line treatment of women with metastatic ... Nitric oxide deficiency raises cardiovascular disease risk in African Americans Publish Date : 6/10/2004 5:14:00 PM African Americans suffer from cardiovascular diseases at a rate about five times higher than the rest of the U.S. population. In a new study, scientists may have found a culprit: a serious deficiency of nitric... New non-aspirin pain drug proves effective against recurrent prostate cancer Publish Date : 6/10/2004 5:11:00 PM Early results from a University of North Carolina at Chapel Hill School of Medicine study may determine if drugs called Cox-2 inhibitors, a newer type of non-aspirin pain medicine now widely prescribed for ... Human subjects play mind games Publish Date : 6/10/2004 5:08:00 PM For the first time in humans, a team headed by researchers at Washington University in St. Louis has placed an electronic grid atop patients'... National Network for Immunization Information statement on new thimerosal study Publish Date : 6/10/2004 5:07:00 PM The following statement can be attributed to Martin G. Myers, MD, executive director of the National Network for Immunization Information (NNii): Tongue studs cause more problems than chipped teeth, recessed gums and nerve damage Publish Date : 6/10/2004 5:05:00 PM Wearing a tongue stud puts people at risk for chipped teeth, recessed gums and nerve damage. However, most people don't realize that getting an oral piercing also places them at risk for developing... Renal Physicians and NIH Release Web Tool to Coordinate Care for Kidney Patients USA Publish Date : 6/10/2004 5:03:00 PM The Renal Physicians Association (RPA) and the National Kidney Disease Education Program (NKDEP) announced today the availability of a Nephrology Total Results : 2455 More News (Opens in New Window) : [1] 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 Next Page |
|